The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUC.L Regulatory News (NUC)

  • There is currently no data for NUC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of long term incentive awards to PDMRs

3 Apr 2019 13:50

RNS Number : 0228V
Nucleus Financial Group PLC
03 April 2019
 

 

 

 

 

 

 

 

3 April 2019

Nucleus Financial Group plc

("Nucleus" or the "Company")

 

 

Grant of long term incentive awards to Executive Directors and other Persons Discharging Managerial Responsibility ("PDMRs")

 

Nucleus announces that, on 3 April 2019, it granted long term incentive awards in the form of nil-cost options ("Awards") over its ordinary shares of 0.1 pence each ("Shares") to the Executive Directors and other PDMRs set out below under the terms of its Long Term Incentive Plan (the "LTIP") that was established at the time of its original admission to AIM.

 

PDMR

Role

No. of Shares over which Awards were granted

David Ferguson

Chief Executive Officer

199,786

Stuart Geard

Chief Financial Officer

134,738

Kirsty Lynagh

Chief People Officer

58,095

Nicola Megaw

Chief Legal Officer and Company Secretary

56,041

Barry Neilson

Chief Customer Officer

73,964

Andrew Smith

Chief Technology Officer

73,406

 

The vesting of each of the Awards is subject to the satisfaction of performance conditions that have been set by the Remuneration Committee of the Company. These conditions (which will be assessed over prescribed three-year periods) relate to the achievement of specified targets applicable to earnings per share, net-inflow of assets under administration and total shareholder return. Vesting will also normally be dependent on the continued employment of the participant within the Company's group. Further details of the LTIP and the performance conditions for the Awards will be included in the Company's 2018 annual report and financial statements.

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

1. David Ferguson

2. Stuart Geard

3. Kirsty Lynagh

4. Nicola Megaw

5. Barry Neilson

6. Andrew Smith

2

 

Reason for the notification

 

a)

 

Position/status

 

 

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief People Officer

4. Chief Legal Officer and Company Secretary

5. Chief Customer Officer

6. Chief Technology Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Nucleus Financial Group plc

b)

 

LEI

 

213800MAIAI3M7LM5950

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 0.1 pence each

 

 

 

 

GB00BG226J60

b)

 

Nature of the transaction

 

Grant of awards (in the form of nil-cost options) over Shares pursuant to the Nucleus Financial Group plc Long Term Incentive Plan

 

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

 

Price(s)

Volume(s)

1.

Nil

199,786

2.

Nil

134,738

3.

Nil

58,095

4.

Nil

56,041

5.

Nil

73,964

6.

Nil

73,406

 

d)

 

Aggregated information

 

 

-Aggregated volume

 

 

- Price

 

 

1. N/A single transaction

2. N/A single transaction

3. N/A single transaction

4. N/A single transaction

5. N/A single transaction

6. N/A single transaction

7. N/A single transaction

e)

 

Date of the transaction

 

3 April 2019

f)

 

Place of the transaction

 

Outside a trading venue

 

 

For further information please contact:

 

Nucleus

Nicola Megaw, Company Secretary

Tel: +44 (0)13 1226 9800

 

Shore Capital (Nominated Adviser & Broker)

Hugh Morgan

Edward Mansfield

Daniel Bush 

Tel: +44 (0)20 7408 4090

Camarco (Media enquiries)

Jennifer Renwick

Jake Thomas

Tel: +44 (0)20 3757 4994

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFSFSFIVIIA
Date   Source Headline
3rd Dec 202011:07 amGNWForm 8.5 (EPT/RI) - Nucleus Financial Group Plc
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
2nd Dec 202012:07 pmRNSStatement regarding a Possible Offer
17th Nov 20207:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSAcquisition of certain assets of OpenWealth
23rd Oct 20207:00 amRNSQ3 2020 AUA update
13th Oct 20201:35 pmRNSDirector/PDMR Shareholding
28th Sep 202012:18 pmRNSDirector/PDMR Shareholding
15th Sep 20209:26 amRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSInterim Results
14th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20207:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSQ2 2020 AUA update
14th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jun 202012:10 pmRNSDirector/PDMR Shareholding
20th May 20203:44 pmRNSGrant of long term incentive awards
20th May 20201:14 pmRNSResult of AGM
14th May 20207:00 amRNSDirector/PDMR Shareholding
15th Apr 20204:13 pmRNSNotice of AGM
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSFinal Results
23rd Mar 20204:40 pmRNSCovid-19 and trading update
17th Mar 20202:28 pmRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSNon-Executive Director Changes
13th Feb 20204:15 pmRNSDirector/PDMR Shareholding
31st Jan 20207:00 amRNSQ4 2019 AUA update
29th Jan 20202:20 pmRNSHolding(s) in Company
15th Jan 20203:43 pmRNSDirector/PDMR Shareholding
16th Dec 20192:37 pmRNSDirector/PDMR Shareholding
22nd Nov 20193:50 pmRNSDirector/PDMR Shareholding
14th Nov 201912:00 pmRNSDirector/PDMR Shareholding
25th Oct 20197:00 amRNSQ3 2019 AUA update
18th Oct 20195:38 pmRNSDirector/PDMR Shareholding
16th Oct 201911:15 amRNSDirector/PDMR Shareholding
17th Sep 20194:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
16th Aug 20197:00 amRNSNotice of Results
15th Aug 20193:58 pmRNSDirector/PDMR Shareholding
26th Jul 20197:00 amRNSQ2 2019 AUA update
16th Jul 20199:00 amRNSDirector/PDMR Shareholding
14th Jun 20194:48 pmRNSDirector/PDMR Shareholding
23rd May 201911:35 amRNSResult of AGM
17th May 20197:00 amRNSDirector/PDMR Shareholding
29th Apr 20197:00 amRNSQ1 2019 AUA update
16th Apr 20191:58 pmRNSDirector/PDMR Shareholding
11th Apr 20192:24 pmRNSPosting of Annual Report and Notice of AGM
4th Apr 20198:20 amRNSHolding(s) in Company
3rd Apr 20191:50 pmRNSGrant of long term incentive awards to PDMRs
2nd Apr 20197:00 amRNSPreliminary results
14th Mar 20194:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.